Streamlining immune cell therapy manufacturing workflows with single-use cytokines
Sponsor
.png "https://www.bio-techne.com/research-areas/immune-cell-therapy"){kind=logo}
Live30 webinars are thirty-minute presentations designed to update you on the latest innovations, applications, and data in a fast yet interactive format.
Transitioning an immune cell therapy program from research to the clinic requires consistent and scalable cell manufacturing processes. Streamlining cell manufacturing workflows by eliminating manual touchpoints reduces variability and supports process scaling.
Cytokine delivery is one such opportunity for workflow improvement. Traditionally, cytokines are supplied in large volumes, which require manual aliquoting prior to storage and use. This step introduces a risk of error, threatens consistency, and impedes scale-up. Bio-Techne has addressed this challenge with new single-use vials with process-optimized concentrations of our GMP cytokines for streamlined immune cell manufacturing.
In this webinar, we examine the workflow difficulties posed by traditional cytokine delivery and the benefits of transitioning to a single-use cytokine method. We will also explore the need for scalable, aseptic closed-systems for immune cell manufacturing and Bio-Techne’s plans to solve that need with complete workflow solutions.
In this webinar, you will learn more about:
- How consistent and scalable manufacturing workflows impact immune cell therapy development
- New single-use cytokines with process-optimized concentrations
- Comparing workflows using traditional and single-use cytokine methods
SPEAKERS
You might also like
Developing off-the-shelf CAR-NK cells targeting CD70: updates from preclinical and early clinical studies
Characterization and release testing for AAV therapies: empty/partial/full capsid analysis and impact on potency
Development of a non-viral gene delivery platform for CAR-T manufacturing
Supporting efficacy and scaling with a next-generation T cell AOF formulation medium
